Loading
Latest filing published 09 Apr 2026 for Adial Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Vinay Shah across 2 companies, led by Adial Pharmaceuticals, Inc. and Aravive, Inc. In total, 2 filings cover trades dated from 29 June 2021 to 7 April 2026.
No open-market sale appears; the market trades are 1 purchase worth €4,461. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant.
The latest filing, published on 9 April 2026, reports a share grant in Adial Pharmaceuticals, Inc. The clock since the last published purchase (29 June 2021) now reads 1,937 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations